May 14, 2026 08:30AM
Mar 4, 2026 04:06PM
Nov 19, 2025 06:01AM
Nov 5, 2025 04:58PM
Oct 20, 2025 06:02AM
Oct 15, 2025 06:30AM
Sep 8, 2025 08:00AM Keros Therapeutics presents KER-065 trial data at bone research meeting
Aug 21, 2025 08:30AM
Aug 20, 2025 09:48AM
Aug 8, 2025 06:22AM
Aug 6, 2025 06:13PM
Aug 6, 2025 04:21PM
Jun 10, 2025 04:16AM
Jun 9, 2025 03:14PM ADAR1 Issues Statement on Keros Therapeutics (KROS) 2025 Director Election Results and Insufficient Capital Return Proposal
Jun 9, 2025 06:55AM
May 29, 2025 06:55AM
May 27, 2025 01:45PM
May 21, 2025 08:06AM
May 8, 2025 02:10PM
May 8, 2025 06:43AM
May 6, 2025 04:20PM Keros Therapeutics (KROS) Tops Q1 EPS by 481c
Apr 10, 2025 02:08PM
Apr 10, 2025 06:19AM
Apr 9, 2025 09:34AM
Mar 31, 2025 06:29AM
Mar 5, 2025 05:48AM
Feb 27, 2025 06:59AM
Feb 26, 2025 06:37PM Keros Therapeutics (KROS) Tops Q4 EPS by 22c
Jan 21, 2025 08:03AM
Jan 21, 2025 06:30AM
Jan 17, 2025 10:40AM
Jan 16, 2025 08:24AM
Jan 16, 2025 06:59AM
Jan 15, 2025 02:57PM
Jan 15, 2025 06:30AM Keros Therapeutics (KROS) Announces Additional Update on the Phase 2 TROPOS Trial
Dec 23, 2024 03:11AM
Dec 16, 2024 07:36AM
Dec 13, 2024 07:17AM
Dec 13, 2024 05:21AM
Dec 12, 2024 09:45AM
Dec 12, 2024 09:05AM
Dec 12, 2024 06:16AM Keros Therapeutics (KROS) Announces Update on the Phase 2 TROPOS Trial
Dec 5, 2024 07:07AM
Dec 3, 2024 10:52AM
Dec 3, 2024 07:00AM
Nov 22, 2024 07:07AM
Nov 5, 2024 01:47PM
Nov 5, 2024 06:06AM
Oct 24, 2024 06:45AM Cantor Fitzgerald Starts Keros Therapeutics (KROS) at Overweight
Oct 16, 2024 08:00AM

409,078 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All